ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SL. Standard Life

410.80
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Standard Life LSE:SL. London Ordinary Share GB00BVFD7Q58 ORD 12 2/9P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 410.80 413.60 413.70 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Standard Life Share Discussion Threads

Showing 9701 to 9724 of 10200 messages
Chat Pages: Latest  396  395  394  393  392  391  390  389  388  387  386  385  Older
DateSubjectAuthorDiscuss
24/1/2017
21:55
From the info above it could be that we do not see an increase in the dividend this year. That won't please some posters on this board who hold here for dividend growth. Nevertheless I'm happy to hold here and believe that we will see a share price of £4 by the end of the year. I also think that Brexit concerns are also holding back the share price
underhill2
24/1/2017
20:20
Now the good news.
Goldman Sachs Group raised Standard Life Plc's price target from £3.65 ($4.56) to £3.70 ($4.62). They now have a "neutral" rating on the stock.

petewy
24/1/2017
18:52
ADVFN Evening Euro Markets Bulletin :

Standard Life retreated after UBS downgraded the stock to 'sell' from 'neutral' and cut the price target to 310p from 320p. "Our rating is driven by our expectation for earnings pressure to emerge in Standard Life Investments in 2017 resulting from increased asset outflows from its flagship £42bn GARS fund.


UBS downgraded Standard Life to 'sell' from 'neutral' and lowered its price target to 310p from 320p on expected earnings pressures from increased outflows from Standard Life Investments.
The Swiss bank changed its rating on its expectation that earnings pressure will emerge in 2017 on SLI due to increased asset outflows from its flagship £42bn Global Absolute Return Strategies (GARS) fund, which is sold on its aim to provide positive investment returns in all market conditions over the medium to long term.

The insurer's share performance is strongly linked to flows and performance of GARS but the fourth quarter of 2016 is estimated to see net outflows increase to around £3bn (including a large UK outflow) compared to the £1.5bn the the third quarter last year.

According to UBS analysts GARS outflows are being particularly caused by structural trends that will be difficult to reverse at least in the near-term.

This includes current performance below its benchmark, fund size constraining scope for longer-term investment outperformance, pension consultants putting the fund on 'watch' and risks to industry multi-asset flows which could fall toward 2013 levels potentially.

The total forecasted multi-asset outflows are £3.9bn for the full year 2016 and £6bn over the full year 2017 resulting in earnings growth of 4%, which is half that of consensus. The bank expects good progress on costs but feels falling revenue will put pressure on ratios.

UBS is however positive on asset growth of 8% per annum to 2018 for UK Life and that the company's 24.1% stake in merged HDFC Life and Max Life could be a source of upside over the medium term.

The earnings per share estimates for 2017 fell by 9% to 27.28p.

samwn1
24/1/2017
17:22
UBS downgraded Standard Life today.
wilky58
24/1/2017
11:00
There must be good reasons for these large daily falls.I would rather have an increasing share price than nice dividends.
underhill2
24/1/2017
09:43
Nearly back to my break even price....oh well divi will help.
chesty1
18/1/2017
14:03
Results in 5 weeks. I Think this will start to motor by the end of January.At least that is what I hope!
fidra
18/1/2017
11:05
Needs a broker's buy note
petewy
16/1/2017
14:54
Agree great dividend if it falls much lower i will add some more.
spcecks
16/1/2017
13:16
Blimey 370 looks a long way off all of a sudden, good job we get a great divi.
chesty1
12/1/2017
14:22
All the way to 4.50
uppompeii
12/1/2017
13:50
Nice reversal, let's hope it holds
rathlindri
11/1/2017
15:28
Yes, fall seems overdone given strength of market. Full year results not that far away and will hopefully give us a boost.
its the oxman
11/1/2017
13:30
Why is this dropping daily I was looking forward to hitting £4... oh well bring on the divi.
chesty1
05/1/2017
18:00
MM games before the big rise I should think, inv H&S chart reinforced. My Forecast 470 within 6 mths
big7ime
05/1/2017
17:19
I bought at 363 and 366, not that that means anything at all.
uppompeii
05/1/2017
16:06
Digital Look has an explanation, saying that SL wasn't rated, which I take to mean that no critique was given either way.
waddy
05/1/2017
16:05
Thanks for the replies and info
rathlindri
05/1/2017
16:02
Life sector as a whole is in a downtrend today
dmf
05/1/2017
15:57
It's a serious fall for a FTSE 100 company on the back of a downgrade on another body.
f1araway
05/1/2017
15:57
Normally a short, sharp fall like this is a broker downgrade. Typically they make a recovery pretty quickly. Also works in reverse. I've just opened an sb@363 - only £25pp - hoping to get 371 before my stop loss (351)
dr biotech
05/1/2017
15:45
Downgrade on RSA today, perhaps doing the damage. PRU weak too

JPMORGAN CUTS RSA INSURANCE TO 'NEUTRAL' ('OVERWEIGHT')

shoee62
05/1/2017
15:45
Blimey, anyone know why the big fall today?
rathlindri
05/1/2017
15:10
Happy to add?You could have added cheaper 3 weeks ago.
f1araway
Chat Pages: Latest  396  395  394  393  392  391  390  389  388  387  386  385  Older

Your Recent History

Delayed Upgrade Clock